Figures & data
Table 1. Studies included in the systematic review.
Table 2. Risk of bias table and modified Jadad score evaluating the quality of randomized controlled trial by Knudson et al. [16].
Modified Jadad score for randomized controlled trial.
Beck DE, Margolin DA, Babin SF, et al. Benefits of a multimodal regimen for postsurgical pain management in colorectal surgery. Ochsner J. 2015;15:408–412. Knudson RA, Dunlavy PW, Franko J, et al. Effectiveness of liposomal bupivacaine in colorectal surgery: a pragmatic nonsponsored prospective randomized double blinded trial in a community hospital. Dis Colon Rectum. 2016;59:862–869. Keller DS, Tahilramani RN, Flores-Gonzalez JR, et al. Pilot study of a novel pain management strategy: evaluating the impact on patient outcomes. Surg Endosc. 2016;30:2192–2198. Cohen SM. Extended pain relief trial utilizing infiltration of Exparel((R)), a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res. 2012;5:567–572. Candiotti KA, Sands LR, Lee E, et al. Liposome bupivacaine for postsurgical analgesia in adult patients undergoing laparoscopic colectomy: results from prospective phase IV sequential cohort studies assessing health economic outcomes. Curr Ther Res Clin Exp. 2014;76:1–6. Stokes AL, Adhikary SD, Quintili A, et al. Liposomal bupivacaine use in transversus abdominis plane blocks reduces pain and postoperative intravenous opioid requirement after colorectal surgery. Dis Colon Rectum. 2017;60:170–177. Keller DS, Pedraza R, Tahilramani RN, et al. Impact of long-acting local anesthesia on clinical and financial outcomes in laparoscopic colorectal surgery. Am J Surg. 2017;214:53–58.